A center for advanced cancer testing and treatment matching
UNITS: The UNC / UT National Clinical Trials Network Group Integrated Translational Science Production and Consultation Center
This study is looking at how to make cancer treatments better by examining the genetic information from tumors, so that doctors can create personalized treatment plans just for you based on your unique tumor characteristics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10811641 on NIH RePORTER |
What this research studies
This research focuses on improving cancer treatment through advanced laboratory techniques that analyze genetic material from tumors. By using methods like DNA and RNA sequencing, the project aims to provide detailed insights into tumor characteristics, which can help tailor therapies to individual patients. The UNC / UTHSC UNITS team will ensure that these high-quality tests are conducted in a compliant manner, allowing for reliable results that can guide treatment decisions. Patients may benefit from personalized treatment plans based on their unique genetic profiles.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with breast cancer or other malignancies who are seeking personalized treatment options.
Not a fit: Patients with non-cancerous conditions or those who do not have a genetic component to their treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments for patients.
How similar studies have performed: Previous research has shown success in using genetic sequencing to inform cancer treatment, making this approach both promising and validated.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Merker, Jason Derek — Univ of North Carolina Chapel Hill
- Study coordinator: Merker, Jason Derek
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.